• Info
  • Significant Ownership

Significant Ownership of C/M CAPITAL PARTNERS, LP

Signature - Title
/s/ Thomas Walsh - Thomas Walsh, Partner
Location
Miami, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by C/M CAPITAL PARTNERS, LP.

Notify me when C/M CAPITAL PARTNERS, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of C/M CAPITAL PARTNERS, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VTAK Catheter Precision, Inc. Common Stock, par value $0.0001 per share 9.6% $413,238 205,591 Jonathan Juchno 06 Feb 2026
BDRX Biodexa Pharmaceuticals Plc Ordinary Shares, nominal value 0.00005 GBP per share 6.8% $2,611,061,100 +$2,611,061,100 1,752,390,000 Jonathan Juchno 20 May 2025
FORD Forward Industries, Inc. Common Stock, par value $0.01 per share 1.6% $35,321,580 +$32,381,669 1,381,368 +1101% C/M CAPITAL PARTNERS, LP 30 Sep 2025
BDRX Biodexa Pharmaceuticals Plc Ordinary Shares, nominal value 0.000001 GBP per share 0% $0 0 Cavalry Fund I LP 30 Jun 2025
AUUD AUDDIA INC. Common Stock, par value $0.001 per share 0% $0 -$71,236 0 -100% Cavalry Fund I LP 30 Sep 2025
IPST Heritage Distilling Holding Company, Inc. Common Stock, par value $0.0001 per share 0% $0 -$1,820,429 0 -100% C/M Capital Master Fund, LP 30 Sep 2025
SLRX Salarius Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 0% $0 0 C/M Capital Master Fund, LP 07 Oct 2025

Schedules 13D/G Reported by C/M CAPITAL PARTNERS, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.